市场调查报告书
商品编码
1439660
手术雷射 - 全球市场考量、竞争状况、市场预测 (2030)Surgical Lasers - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
2023年全球手术雷射器市场规模将达到18.3167亿美元,2030年将达到27.7261亿美元,预计2024-2030年期间复合年增长率为7.26%。 由于技术进步、急性和慢性疾病,特别是眼科和肿瘤疾病的发病率和盛行率的增加,市场呈现出积极的增长。 此外,在2024-2030年的预测期内,广泛的应用、对微创手术的日益偏好以及老年人口的增加都将促进手术雷射市场的成长。
手术雷射市场动态
在手术雷射市场,由于多种原因,产品需求不断增加。 主要因素包括世界各地产品领域的技术进步和产品发布。
例如,2022 年 9 月,蔡司发布了 ZEISS VISUMAX 800。 这种新一代飞秒雷射透过数位连接的角膜屈光工作流程,透过轻鬆的治疗计划和数据分析来减少雷射时间和潜在的转录错误,从而为患者和外科医生提供舒适的体验。
此外,LENSAR还推出了用于白内障手术的下一代飞秒雷射技术-ALLY(TM)系统,并在2022年美国白内障和屈光手术学会(ASCRS)年会上公布了多项数据。 LENSAR 计划于 2022 年第一季提交 510(k) 申请,以获得 ALLY 的监管批准,预计于 2022 年下半年投入商业使用。
2020 年 7 月,SCHWIND Eye-tech 解决方案的 SCHWIND ATOS 飞秒雷射器获得了 CE 批准。
此外,由于微创手术日益普及,手术雷射市场的产品需求正在激增。 儘管开放性手术仍然是标准手术,但开放性手术的缺点,例如手术併发症风险增加和癒合时间长,成为微创手术发展的催化剂。 手术雷射具有精确性、稳定性和与现代技术的集成,以及针对个别手术专业的多种其他优势。 因此,此类系统预计将彻底改变外科领域。 因此,由于手术雷射在医疗领域的优势,预计2024-2030年预测期内手术雷射市场的成长前景将是良好的。
然而,雷射设备的高成本以及与雷射相关的安全问题等某些因素可能会对手术雷射市场的成长产生一定的限制。
COVID-19 大流行的爆发对世界各地产生了重大影响。 由于 COVID-19 大流行,患者非常不愿意接受白内障和屈光手术等选择性治疗。 手术数量明显减少。 一项研究显示,2020年3月下半月,全球手术数量比2019年同期减少了25%,就诊患者数量减少了约50%。 一旦解除封锁限制,所有专业对手术雷射的需求都激增。 这导致大流行后全球手术雷射市场加速成长。
手术雷射市场细分分析
在手术雷射市场的手术领域,CO2气体雷射系统预计在预测期内(2024-2030年)将占较高占有率。 这可能是由于与这些雷射相关的特性所造成的。
该产品领域的庞大市场占有率可归因于患者采用这些设备和快速治疗。 CO2 气体雷射系统的主要优点是它们能够以相对效率产生非常高的功率。 因此,它主要用于材料加工应用。
本报告提供了全球手术雷射市场的研究和分析,包括市场规模和预测、驱动因素和挑战以及公司和产品概况。
Surgical Lasers Market By Product (Solid-State Laser Systems [Erbium Yttrium Aluminum Garnet (ER: YAG), Neodymium Yttrium Aluminum Garnet (ND: YAG), Holmium Yttrium Aluminum Garnet (HO: YAG), Others], Gas Laser Systems [Co2, Argon, Excimer, Others], Diode Laser Systems, Others), By Procedure (Open Surgery, Laparoscopic Surgery, Percutaneous Surgery, Others), By Application (Cosmetic, Dental, Ophthalmic, Gynecology, Others), By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to the technological advancements and growing preference for minimally invasive surgeries
The global surgical lasers market was valued at USD 1,831.67 million in 2023, growing at a CAGR of 7.26% during the forecast period from 2024 to 2030 to reach USD 2,772.61 million by 2030. The Surgical Lasers market is witnessing positive growth owing to the technological advancements, increasing incidence and prevalence of acute and chronic disorders, particularly ophthalmic disorders and oncological disorders. In addition, a wide variety of applications, growing preference for minimally invasive surgeries, rising geriatric population are thereby contributing to the growth of the Surgical Lasers market during the forecast period from 2024-2030.
Surgical Lasers Market Dynamics:
The Surgical Lasers market is witnessing a growth in product demand owing to various reasons. The key factor includes the technological advancements and product launches that are taking place in the product arena across the globe.
For instance, in September 2022, ZEISS introduced the ZEISS VISUMAX 800, the next generation femtosecond lasers that create a comfortable patient and surgeon experience by reducing laser time and potential transcription errors with easy treatment planning and data analysis via a digitally connected corneal refractive workflow.
In addition, LENSAR announced its next-generation femtosecond laser technology ALLY(TM) System, used in cataract surgery, and presented multiple data at the American Society of Cataract and Refractive Surgery (ASCRS) 2022 Annual Meeting. LENSAR expects to submit a 510(k) application for regulatory clearance of ALLY in the first quarter of 2022, with a commercial launch planned for later in 2022.
In July 2020, SCHWIND eye-tech solutions received CE approval for the SCHWIND ATOS femtosecond laser.
Moreover, the Surgical Lasers market is witnessing a surge in product demand due to the growing popularity of minimally invasive procedures. Even though open surgeries are still a norm, the disadvantages associated with open surgery such as the increased risk of procedural complications, longer healing time acted as a catalyst in the development of minimally invasive procedures. Surgical Lasers offer accuracy, stability, integration with modern technology, in addition to multiple other benefits exclusive to individual surgical specialties. As a result, such systems are expected to revolutionize the field of surgery. Thus, owing to the advantages associated with surgical lasers in the medical field, the growth prospect of the Surgical Lasers market appears to be lucrative during the forecast period from 2024-2030.
However, certain factors such as the high cost of laser devices and the safety concerns associated with lasers may be certain limiting factors of the Surgical Lasers market growth.
The outbreak of the COVID-19 pandemic had a profound impact across the globe. Patients were highly unwilling to seek elective health treatment, such as cataracts and refractive surgery, as a result of the COVID-19 epidemic. The number of surgeries performed decreased considerably. As per the research studies, in the second half of March 2020, 25% fewer surgical operations were done than in the same time in 2019, and the number of patients seen in the clinic fell by roughly 50% globally. Once the lockdown restrictions were uplifted, the demand surged across all the specialty areas for surgical lasers. This led to accelerating the growth of the Global Surgical Lasers market post-pandemic.
Surgical Lasers Market Segment Analysis:
Surgical Lasers Market By Product (Solid-state Laser Systems [Erbium Yttrium Aluminum Garnet (Er: YAG), Neodymium Yttrium Aluminum Garnet (Nd: YAG), Holmium Yttrium Aluminum Garnet (Ho: YAG), Others], Gas Laser Systems [CO2, Argon, Excimer, Others], Diode Laser Systems, Others), By Procedure (Open Surgery, Laparoscopic Surgery, Percutaneous Surgery, Others), By Application (Cosmetic, Dental, Ophthalmic, Gynecology, others), By End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the Procedure segment of the Surgical Lasers market, the CO2 Gas Laser Systems is estimated to hold a higher share in the Surgical Lasers market during the forecast period (2024-2030). This can be attributed to the specific features associated with these lasers.
The large market share of this product segment can be attributed to the growing patient adoption of these devices and quick treatment. The main benefit of CO2 Gas Laser Systems is that it produces very high power with relative efficiency. Hence it is used primarily for materials processing applications.
CO2 laser offers low cost per watt in addition to good beam quality. It generates high power output which ranges from a few watts to 15 KWatts.
Another major advantage of using the CO2 laser is the minimized charring with faster healing which increases patients' motivation for treatment, but caution is necessary with regard to recurrence.
Therefore, it is expected that with such advantages offered by the CO2 Gas Laser Systems, this product is expected to increase its penetration in coming years, thus this will drive the segment to grow during the forecast period, which will have a positive impact on the overall Global Surgical Lasers Market growth.
Furthermore, CO2 Gas Laser Systems are gaining commercial acceptability, which also improves market penetration. All these advantages of such devices make physicians more inclined to use CO2 Gas Laser Systems.
Hence, all the above-mentioned factors are expected to drive the segment growth of the Surgical Lasers market.
North America is expected to dominate the overall Surgical Lasers Market:
Among all the regions, North America is expected to account for the largest share in the Global Surgical Lasers market. Factors such as the increasing incidence and prevalence of acute and chronic disorders, particularly in ophthalmic disorders and oncological disorders among others. In addition, a wide variety of surgical applications and rising product launches in the region are expected to aid in the growth of the North America Surgical Lasers Market.
As per CDC 2020, approximately 12 million people 40 years and over in the United States have vision impairment, including 1 million who are blind, 3 million who have vision impairment after correction, and 8 million who have vision impairment due to uncorrected refractive error.
Additionally, according to Cancer Vision 2020, based on the trends in the surgical volume of cataract surgery over the past decade, 3.7 million cataract cases would have been performed in 2020 in the United States among Medicare beneficiaries.
According to the New Plastic Surgery Statistics released by the American Society of Plastic Surgeons (ASPS) shows there were nearly a quarter-million more cosmetic procedures performed in 2018 than in the year 2017. Also, according to the ASPS annual plastic surgery statistics report, there were more than 17.7 million surgical and minimally-invasive cosmetic procedures performed in the United States in 2018. The statistics also revealed a rise in new trends in body-shaping procedures, with a spike in non-invasive fat reduction, as well as surgeries such as breast augmentations and liposuction.
Hence, Minimally Invasive Surgery approaches such as the use of Surgical Lasers are gaining popularity owing to their precision and minimal invasion in the surrounding anatomy. Furthermore, Surgical Lasers are being preferred by surgeons for conducting numerous surgical procedures due to aided benefits of precision and accuracy and better chances of reproducing positive surgical outcomes which further helps in faster recovery for patients. Therefore, the Surgical Lasers market is slated to register remarkable growth during the forecast period (2024-2030) owing to the factors mentioned above.
Another factor responsible for the growth of the Surgical Lasers market is the launch of new products in the region. For instance, in March 2019, Sciton Inc., a manufacturer of aesthetic and medical laser and light source technology, launched the latest version of its flagship platform JOULE X at the American Society of Laser Medicine and Surgery (ASLMS) annual meeting in Colorado., Canada. JOULE X is a multi-device platform with customizable laser and light performance.
Thus, these factors are projected to contribute to the Surgical Lasers market during the forecast period.
The rising adoption of Surgical Lasers in the country would result in the rising demand for procedures that make use of Surgical Lasers, which in turn would provide a conducive growth environment for the United States Surgical Lasers market as well as the North American region. Therefore, the interplay of various factors such as the presence of a large patient population, encouraging reimbursement policies as well as new product launches in the region is expected to boost the North America Surgical Lasers market during the forecast period.
Surgical Lasers Market Key Players:
Some of the key market players operating in the Surgical Lasers market include LightScalpel, Quanta System, KLS Martin Group, Lumenis Be Ltd. (Boston Scientific Corporation), INTERmedic Arfran, Cynosure (Hologic), Alma Lasers, Johnson & Johnson Vision Care, Inc., IPG Photonics Corporation, Koninklijke Philips N.V., biolitec® AG, Fotona, BISON MEDICAL, Alcon Laboratories, Inc., A.R.C. Laser GmbH, Ziemer Ophthalmic Systems, Carl Zeiss Meditec AG, MEDA Co., Ltd., LIGHTMED, NIDEK CO., LTD., and others.
Recent Developmental Activities in the Surgical Lasers Market:
In September 2022, Boston Scientific announced the closure of its acquisition of the global surgical business of Lumenis LTD., a privately-held company that develops and commercializes energy-based medical solutions, from an affiliate of Baring Private Equity Asia (BPEA). The Lumenis surgical business includes premier laser systems, fibers, and accessories used for urology and otolaryngology procedures with total revenue anticipated to be approximately $200 million for full-year 2022.
Key Takeaways from the Surgical Lasers Market Report Study
Target Audience who can be benefited from this Surgical Lasers Market Report Study
Frequently Asked Questions for the Surgical Lasers Market:
According to FDA, Surgical Lasers are devices used to precisely focus light sources to treat or remove tissues. Because lasers can focus very accurately on tiny areas, they can be used for very precise surgical work or for cutting through tissue.
The global surgical lasers market was valued at USD 1,831.67 million in 2023, growing at a CAGR of 7.26% during the forecast period from 2024 to 2030 to reach USD 2,772.61 million by 2030.
The Surgical Lasers market is witnessing a positive market growth owing to the technological advancements, increasing incidence and prevalence of acute and chronic disorders, particularly in ophthalmic disorders and oncological disorders among others. In addition, a wide variety of applications, growing preference for minimally invasive surgeries, rising geriatric population is thereby contributing to the growth of the Surgical Lasers market.
Some of the key market players operating in the Surgical Lasers market include LightScalpel, Quanta System, KLS Martin Group, Lumenis Be Ltd. (Boston Scientific Corporation), INTERmedic Arfran, Cynosure (Hologic), Alma Lasers, Johnson & Johnson Vision Care, Inc., IPG Photonics Corporation, Koninklijke Philips N.V., biolitec® AG, Fotona, BISON MEDICAL, Alcon Laboratories, Inc., A.R.C. Laser GmbH, Ziemer Ophthalmic Systems, Carl Zeiss Meditec AG, MEDA Co., Ltd., LIGHTMED, NIDEK CO., LTD., and others.
North America is expected to hold the highest share in the revenue in the Surgical Lasers market during the forecast period. Factors such as the increasing incidence and prevalence of acute and chronic disorders, particularly in ophthalmic disorders and oncological disorders among others. In addition, a wide variety of surgical applications and rising product launches in the region, are expected to aid in the growth of the North America Surgical Lasers Market in this region.